UK pharma major GSK (LSE: GSK) has published results from its Phase III MATINEE trial evaluating Nucala (mepolizumab) in ...

UK regulators are set to review a proposed label update for Eisai (TYO: 4523) and Biogen’s (Nasdaq: BIIB) Alzheimer’s drug ...

The Russian drugmaker Akrikhin has filed a lawsuit against UK pharma major AstraZeneca (LSE: AZN) to the Moscow Intellectual ...

Shanghai-based biotech Shijian Bio has signed an exclusive option agreement with US firm ConjugateBio to license its EZWi-Fit ...

A San Francisco-based biopharma company developing a topical protein therapy for dystrophic epidermolysis bullosa (DEB).

US pharma giant Merck & Co has started building a $1 billion, 470,000-square-foot biologics center of excellence in ...

US biotech firm Stealth BioTherapeutics (OTCQB: MITO) is facing renewed uncertainty after the American medicines regulator ...

US biotech Transneural Therapeutics has named industry veteran Mark Demitrack as its chief research and development officer, ...

Regulus Therapeutics (Nasdaq: RGLS) saw its shares leap 133% to $7.84 in pre-market activity this morning, on the news it has ...

Chicago-based drugmaker AbbVie has announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), ...

Swiss generics and biosimilars major Sandoz (SIX: SDZ) has signed a global collaboration with Shanghai Henlius Biotech (HKEX: ...

The Russian pharmaceutical market grew up to 814 billion roubles ($10 billion) in the first quarter of 2025, 11% higher ...